article thumbnail

Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’

pharmaphorum

The new tool can be used by labs to support their own COVID-19 research projects on their local patient base, and in turn could be used by pharma companies that are developing candidates vaccines and antiviral therapies.

Genetics 136
article thumbnail

Scrutinizing the West Syndrome Market Space from Growth Perspectives

Delveinsight

It can be due to the previous existence of brain damage signs (psychomotor retardation, neurologic signs, radiologic signs, or other types of seizures) or on the basis of etiology that is characterized by a lack of previous signs of brain damage. There are many different causes of epileptic spasms.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Medical Metaverse Digest for June 30

Intouch Solutions

Pharma companies in the metaverse? From monitoring diseases and viruses; to improving clinical research and medical records; to guarding data, privacy and records, and more: this article lays out a variety of ways that blockchain can and should be used to improve healthcare. – made a purchase inside a metaverse.

article thumbnail

What will the 2023 drug discovery landscape look like?

Drug Discovery World

But Jeffrey Petrella, Professor of Radiology and Director of the Alzheimer Imaging Research Laboratory at Duke University School of Medicine, says: “Despite these limitations, this is the first step towards tailored clinical trials. However, it also made great strides in proving the success of these sorts of trials.